The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1 beta and of the type I and type IIIL-1 receptors
S. Kol et al., The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1 beta and of the type I and type IIIL-1 receptors, MOL C ENDOC, 149(1-2), 1999, pp. 115-128
An increasing body of evidence supports the possibility that intraovarian i
nterleukin (IL)-1 plays an intermediary role in the perovulatory cascade. T
o gain further insight into the intraovarian IL-1 hypothesis, we studied th
e cellular localization cyclic variation and hormonal regulation of IL-1 be
ta, as well as of the type I and type II IL-1 receptors (IL-1R) in immature
rats. In situ hybridization localized IL-I beta and type I IL-1R transcrip
ts to the granulosa cell compartment, the innermost layers of the theca int
erna and to the oocyte of the untreated immature ovary. Molecular probing o
f whole ovarian material in the course of a simulated estrous cycle reveale
d a progressive preovulatory increase in IL-1 beta and type I IL-1R transcr
ipts to an in vivo peak at the time of ovulation (3.0- and 2.5-fold increas
es over untreated controls; P < 0.05). Comparable efforts to localize and p
robe for type II IL-1R transcripts failed to elicit a detectable signal. Th
e basal in vitro expression pattern of IL-1 beta and type II IL-IR transcri
pts by whole ovarian dispersates revealed an early (4 h) spontaneous increa
se to a peak (2.1- and 5.8-fold increases over time 0; P < 0.05) followed b
y a gradual decline to a 48 h nadir. Treatment of whole ovarian dispersates
with the IL-1 receptor antagonist (IL-1RA) or with IL-1 beta failed to alt
er the initial (4 h) burst of IL-IP or of type II IL-1R expression thereby
suggesting IL-1-independence. Treatment with hCG proved equally ineffective
. However, longer-term treatment of whole ovarian dispersates with IL-1 bet
a produced a significant secondary increase (5.9-fold over time 0; P < 0.05
) in IL-IP (but not type II IL-1R) transcripts by 48 h. This IL-1 effect wa
s completely blocked by co-treatment with IL-1RA thereby suggesting mediati
on via a specific IL-1 receptor. Qualitatively comparable but quantitativel
y reduced results obtained for isolated granulosa cells. The basal in vitro
expression pattern of type I IL-IR transcripts by whole ovarian dispersate
s revealed a progressive spontaneous increase (3.1-fold increase overall) o
ver the 48 h culture. Treatment with IL-1 beta produced a significant (P <
0.05) increase (5-fold) in type I IL-1R transcripts by 48 h, an effect whic
h was completely blocked by co-treatment with IL-IRA. Taken together, these
observations: (1) localize IL-IP and its type I receptor to granulosa cell
s, the innermost layers of the theca interna and to the oocyte; (2) confirm
their periovulatory in vivo expression pattern; (3) document their express
ion by untreated cultured whole ovarian dispersates; and (4) demonstrate th
eir in vitro responsiveness to receptor-mediated/IL-1-driven autocrine ampl
ification. The type II IL-1R was undetectable in vivo, its in vitro express
ion pattern proving IL-1- and hCG-independent. The periovulatory expression
pattern of IL-1 beta and its receptor (type I) is compatible with the noti
on that the intraovarian IL-I system may play an intermediary role in the o
vulatory process. (C) 1999 Published by Elsevier Science Ireland Ltd. All r
ights reserved.